BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2406205)

  • 1. Importance of interferon alpha in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver.
    Gresser I; Maury C; Bandu MT; Belardelli F
    Int J Cancer; 1990 Feb; 45(2):364-71. PubMed ID: 2406205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.
    Gresser I; Maury C; Vignaux F; Haller O; Belardelli F; Tovey MG
    J Exp Med; 1988 Oct; 168(4):1271-91. PubMed ID: 3171480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.
    Gresser I; Kaido T; Maury C; Woodrow D; Moss J; Belardelli F
    Int J Cancer; 1994 May; 57(4):604-11. PubMed ID: 8181864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
    Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
    Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.
    Kaido T; Gresser I; Maury C; Maunoury MT; Vignaux F; Belardelli F
    Int J Cancer; 1993 May; 54(3):475-81. PubMed ID: 8509222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.
    Gresser I; Carnaud C; Maury C; Sala A; Eid P; Woodrow D; Maunoury MT; Belardelli F
    J Exp Med; 1991 May; 173(5):1193-203. PubMed ID: 2022926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases.
    Gresser I; Maury C; Carnaud C; De Maeyer E; Maunoury MT; Belardelli F
    Int J Cancer; 1990 Sep; 46(3):468-74. PubMed ID: 2394514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
    Gresser I; Maury C; Woodrow D; Moss J; Grütter MG; Vignaux F; Belardelli F; Maunoury MT
    Int J Cancer; 1988 Jan; 41(1):135-42. PubMed ID: 3422071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells.
    Ferrantini M; Pulciani S; Proietti E; Lespinats G; Anastasi A; Ciolli V; Rizza P; Belardelli F
    Clin Exp Metastasis; 1989; 7(6):609-25. PubMed ID: 2476272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.
    Sala A; Gresser I; Chassoux D; Maury C; Santodonato L; Eid P; Maunoury MT; Barca S; Cianfriglia M; Belardelli F
    Cancer Res; 1992 May; 52(10):2880-9. PubMed ID: 1581903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal administration of IFN-alpha/beta inhibits the development of visceral tumor metastases.
    Kaido TJ
    J Interferon Cytokine Res; 1997 Jan; 17(1):31-6. PubMed ID: 9041469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.
    Santodonato L; Ferrantini M; Gabriele L; Proietti E; Venditti M; Musiani P; Modesti A; Modica A; Lupton SD; Belardelli F
    Hum Gene Ther; 1996 Jan; 7(1):1-10. PubMed ID: 8825863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.
    Gabriele L; Kaido T; Woodrow D; Moss J; Ferrantini M; Proletti E; Santodonato L; Rozera C; Maury C; Belardelli F
    Am J Pathol; 1995 Aug; 147(2):445-60. PubMed ID: 7639337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells.
    Gresser I; Maury C; Kaido T; Bandu MT; Tovey MG; Maunoury MT; Fantuzzi L; Gessani S; Greco G; Belardelli F
    Int J Cancer; 1995 Nov; 63(5):726-31. PubMed ID: 7591292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
    Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
    Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
    DiCicco LM; Truitt GA; Wheelock EF
    Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute rejection of interferon-treated leukemia cells injected into lethally irradiated syngeneic mice.
    Neri M; Zei T; Tentori L; Bonmassar E; Affabris E; Iorio AM
    Nat Immun; 1993; 12(6):302-15. PubMed ID: 7505668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the site of tumor growth on the capacity of a low tumorigenic line of Friend erythroleukemia cells to differentiate.
    Gresser I; Moss J; Woodrow D; Le Bousse C; Maury C; Proietti E; Belardelli F
    Am J Pathol; 1991 May; 138(5):1125-33. PubMed ID: 2024705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural resistance in mice against Friend leukemia cells. I. Studies with in vitro passaged interferon-sensitive and interferon-resistant cell clones.
    Iorio A; Neri M; Federico M; Rossi GB; Bonmassar E
    Cell Immunol; 1986 Mar; 98(1):230-7. PubMed ID: 2427224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.